Detalhe da pesquisa
1.
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
J Immunol
; 207(3): 878-887, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301847
2.
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.
J Biol Chem
; 296: 100536, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33716040
3.
Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2.
J Biol Chem
; 297(5): 101241, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735911
4.
The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice.
Elife
; 102021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34821555
5.
Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants.
Front Immunol
; 12: 757197, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34691078
6.
Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.
J Biotechnol
; 151(4): 357-62, 2011 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21219947
7.
The B-domain of Factor VIII reduces cell membrane attachment to host cells under serum free conditions.
J Biotechnol
; 147(3-4): 198-204, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20438774